-+ 0.00%
-+ 0.00%
-+ 0.00%

enGene Therapeutics held annual shareholder meeting

PUBT·06/10/2026 20:10:50
Listen to the news
enGene Therapeutics held annual shareholder meeting
  • enGene Therapeutics held its annual general meeting on June 9, 2026.
  • Shareholders backed the board’s slate of director nominees.
  • Shareholders ratified the appointment of the company’s auditor, with authority granted to set the auditor’s remuneration.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. enGene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-265830), on June 10, 2026, and is solely responsible for the information contained therein.